Cumberland Pharmaceuticals (CPIX) Reports Q3 Loss of $0.11

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. FIX
9. TSCO
10. BE

Go back to Cumberland Pharmaceuticals (CPIX) Reports Q3 Loss of $0.11

Cumberland Pharmaceuticals Reports Third Quarter 2024 Financial Results and Company Update

November 7, 2024 4:05 PM EST

        New Real World Study of 150,000 Patients Favors Caldolor over ketorolac  

        DMD Program Receives FDA Orphan Drug & Rare Pediatric Disease Designations  

NASHVILLE, Tenn., Nov. 7, 2024 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company, today announced that its portfolio of FDA-approved brands delivered combined revenues of $9.1 million during the third quarter of 2024. The company ended the third quarter of 2024 with $77 million in total assets, $52 million in... More